Back to search
Pseudohypoparathyroidism Type 1a
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Pseudohypoparathyroidism Type 1a trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Pseudohypoparathyroidism Type 1a trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The investigators plan to test the efficacy and safey of 6-months of open-label setmelanotide to treat obesity in a single patient with pseudohypoparathyroidism…
We, the researchers, are following the natural history of Albright hereditary osteodystrophy. We have found that growth hormone deficiency is very common in pat…